Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MS vs MRNA✓SelectedUSD · MRNAMS vs MRNA performance historyLatest closeAs of-1.29%11/18
Stock and ETF performance explorer

MS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+457.5%
MRNA return
+794.5%
Excess return
-337.0%
Maximum drawdown
-51.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.3%-4.8%+3.6%-1.1%
7D-5.0%-20.9%+15.9%-4.2%
30D+2.1%-13.3%+15.4%+2.6%
3M-16.2%+212.6%-228.8%-21.7%
6M-4.9%+309.0%-313.9%-12.9%
YTD+4.4%+567.3%-562.9%-7.7%
1Y+15.9%+689.7%-673.8%+1.4%
3Y+145.9%+157.4%-11.6%+124.1%
5Y+117.3%-21.7%+139.0%+102.4%
All+457.5%+794.5%-337.0%+387.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling